Search research articles
Contact Us
Filters
Showing results (211-220 of 221) with videos related to
Page
of 23
Sort By:
Journal of Clinical Gastroenterology
|
June 6, 2020
Novel Orally Administered Recombinant Anti-TNF Alpha Fusion Protein for the Treatment of Ulcerative Colitis: Results From a Phase 2a Clinical Trial
Einat Almon, Yoseph Shaaltiel, Wisam Sbeit, et al.
ACS Medicinal Chemistry Letters
|
August 20, 2015
Suppression of Hepatocellular Carcinoma by Inhibition of Overexpressed Ornithine Aminotransferase
Ehud Zigmond, Ami Ben Ya'acov, Hyunbeom Lee, et al.
Neurobiology of Disease
|
August 17, 2005
Endocannabinoids affect neurological and cognitive function in thioacetamide-induced hepatic encephalopathy in mice
Yosefa Avraham, Eran Israeli, Ezra Gabbay, et al.
Journal of Inflammation Research
|
October 23, 2014
β-glycosphingolipids ameliorated non-alcoholic steatohepatitis in the Psammomys obesus model
Ehud Zigmond, Oshrat Tayer-Shifman, Gadi Lalazar, et al.
The American Journal of Gastroenterology
|
November 26, 2003
Treatment of chronic hepatitis B virus infection via oral immune regulation toward hepatitis B virus proteins
Rifaat Safadi, Eran Israeli, Orit Papo, et al.
Journal of Clinical Immunology
|
April 17, 2015
Oral Administration of OKT3 MAb to Patients with NASH, Promotes Regulatory T-cell Induction, and Alleviates Insulin Resistance: Results of a Phase IIa Blinded Placebo-Controlled Trial
Gadi Lalazar, Meir Mizrahi, Ilit Turgeman, et al.
Journal of Cystic Fibrosis : Official Journal of the European Cystic Fibrosis Society
|
May 30, 2018
Primary sclerosing cholangitis is associated with abnormalities in CFTR
Steven Werlin, Virginie Scotet, Kevin Uguen, et al.
Journal of Hepatology
|
January 18, 2011
Reduced dose and duration of peginterferon alfa-2b and weight-based ribavirin in patients with genotype 2 and 3 chronic hepatitis C
Michael Manns, Stefan Zeuzem, Ajit Sood, et al.
Journal of Clinical Immunology
|
September 17, 2009
Oral administration of OKT3 monoclonal antibody to human subjects induces a dose-dependent immunologic effect in T cells and dendritic cells
Yaron Ilan, Ehud Zigmond, Gadi Lalazar, et al.
Npj Imaging
|
March 26, 2026
Cross-disciplinary methodologies for whole-person research - insights from EMPOWER2024
Irène Buvat, Erik Aarntzen, Ramsey D Badawi, et al.
Page
of 23
Search research articles
Search
Showing results (211-220 of 221) with videos related to
Sort By:
Page
of 23
Journal of Clinical Gastroenterology
|
June 6, 2020
Novel Orally Administered Recombinant Anti-TNF Alpha Fusion Protein for the Treatment of Ulcerative Colitis: Results From a Phase 2a Clinical Trial
Einat Almon, Yoseph Shaaltiel, Wisam Sbeit, et al.
ACS Medicinal Chemistry Letters
|
August 20, 2015
Suppression of Hepatocellular Carcinoma by Inhibition of Overexpressed Ornithine Aminotransferase
Ehud Zigmond, Ami Ben Ya'acov, Hyunbeom Lee, et al.
Neurobiology of Disease
|
August 17, 2005
Endocannabinoids affect neurological and cognitive function in thioacetamide-induced hepatic encephalopathy in mice
Yosefa Avraham, Eran Israeli, Ezra Gabbay, et al.
Journal of Inflammation Research
|
October 23, 2014
β-glycosphingolipids ameliorated non-alcoholic steatohepatitis in the Psammomys obesus model
Ehud Zigmond, Oshrat Tayer-Shifman, Gadi Lalazar, et al.
The American Journal of Gastroenterology
|
November 26, 2003
Treatment of chronic hepatitis B virus infection via oral immune regulation toward hepatitis B virus proteins
Rifaat Safadi, Eran Israeli, Orit Papo, et al.
Journal of Clinical Immunology
|
April 17, 2015
Oral Administration of OKT3 MAb to Patients with NASH, Promotes Regulatory T-cell Induction, and Alleviates Insulin Resistance: Results of a Phase IIa Blinded Placebo-Controlled Trial
Gadi Lalazar, Meir Mizrahi, Ilit Turgeman, et al.
Journal of Cystic Fibrosis : Official Journal of the European Cystic Fibrosis Society
|
May 30, 2018
Primary sclerosing cholangitis is associated with abnormalities in CFTR
Steven Werlin, Virginie Scotet, Kevin Uguen, et al.
Journal of Hepatology
|
January 18, 2011
Reduced dose and duration of peginterferon alfa-2b and weight-based ribavirin in patients with genotype 2 and 3 chronic hepatitis C
Michael Manns, Stefan Zeuzem, Ajit Sood, et al.
Journal of Clinical Immunology
|
September 17, 2009
Oral administration of OKT3 monoclonal antibody to human subjects induces a dose-dependent immunologic effect in T cells and dendritic cells
Yaron Ilan, Ehud Zigmond, Gadi Lalazar, et al.
Npj Imaging
|
March 26, 2026
Cross-disciplinary methodologies for whole-person research - insights from EMPOWER2024
Irène Buvat, Erik Aarntzen, Ramsey D Badawi, et al.
Page
of 23